Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
Branimir Gjurašin, Mia Jeličić, Marko Kutleša, et al.
Life (2022) Vol. 13, Iss. 1, pp. 36-36
Open Access | Times Cited: 12

Showing 12 citing articles:

Steatotic Liver Disease and Sepsis Outcomes—A Prospective Cohort Study (SepsisFAT)
Juraj Krznarić, Neven Papić, Nina Vrsaljko, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 798-798
Open Access | Times Cited: 5
Nonalcoholic Fatty Liver Disease Increases the Risk of Lung Abscess: Findings from a Nationwide Cohort Study
Eunso Lee, Jungok Kim, Sun-Young Yoon
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 542-542
Open Access
The Impact of Steatotic Liver Disease on Cytokine and Chemokine Kinetics During Sepsis
Nina Vrsaljko, Leona Radmanić, Snježana Židovec Lepej, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2226-2226
Open Access
Man-Made Disasters
Jagriti Ramanathan
(2025), pp. 145-174
Closed Access
Metabolic dysfunction associated steatotic liver disease is associated with an increased risk of multiple respiratory system diseases
Bofu Liu, Jia Yu, Zhihan Gu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
Frano Šušak, Nina Vrsaljko, Adriana Vince, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1571-1571
Open Access | Times Cited: 7
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis(2000-2019)
Xiuhong Lyu, Bolun Liu, Yiting Li, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000–2019)
Xiuhong Lyu, Bolun Liu, Yiting Li, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5737-5737
Open Access | Times Cited: 1
Patients with atrial fibrillation and diabetes mellitus affected by nonalcoholic fatty liver disease have a greater risk of mortality and worse clinical outcomes
Leonid Khokhlov, Bekure B. Siraw, Mehnaaz Ali, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 1
Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP)
Xiao-Jiao Cui, Bo Xie, Ke‐Wei Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States
Aakriti Soni
Annals of Gastroenterology (2023)
Open Access | Times Cited: 2
COVID-19 and Fatty Liver Disorders
Maria Guarino, Valentina Cossiga, Francesco Cutolo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4316-4316
Open Access | Times Cited: 2
COVID-19 severity and nonalcoholic fatty liver disease
Nina Vrsaljko, Branimir Gjurašin, Neven Papić
Elsevier eBooks (2024), pp. 457-463
Closed Access
Page 1

Scroll to top